Consensus NovaBay Pharmaceuticals, Inc.

Equities

NBY

US66987P4090

Market Closed - Nyse 16:00:00 2024-06-14 EDT 5-day change 1st Jan Change
2.51 USD -2.33% Intraday chart for NovaBay Pharmaceuticals, Inc. -7.38% -64.85%

Evolution of the average Target Price on NovaBay Pharmaceuticals, Inc.

Price target over the last 5 years

History of analyst recommendation changes

0eadbf24a217ca61ed60e9d83eee61.3Qe-uEIl4F2PnOhXoIMgi9GjKZER1Nkql9hakYcamv4.mTX48jFIqRXc2N0imdNE3LaWGetSvpFI4Yo5-cJL7p-Fd-_pI0uMMOvfpQ~44c9ad8445d376a51b6753329765102d

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
2.51 USD
Average target price
58.62 USD
Spread / Average Target
+2,235.66%
High Price Target
61.25 USD
Spread / Highest target
+2,340.24%
Low Price Target
56 USD
Spread / Lowest Target
+2,131.08%

Consensus detail

Consensus revision (last 18 months)

Analysts covering NovaBay Pharmaceuticals, Inc.

Ladenburg Thalmann
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
  1. Stock Market
  2. Equities
  3. NBY Stock
  4. Consensus NovaBay Pharmaceuticals, Inc.